SlideShare a Scribd company logo
What is
40 : 1
In management of
Dr. Jyoti Agarwal
Dr. Sharda Jain
Dr. Jyoti Bhaskar
Not end of the story
Today knowledge regarding PCOS
has revived and efforts have been undertaken
to explore new options
created significant
development in t/t of
PCOD
Indian Journal of Endocrinology and Metabolism, 2011
Central player : IR
Insulin Resistance
A pathophysiological contributor in
50 – 80 % of the PCOS women
Indian J Endocrinol Metab. 2011 Oct-Dec; 15(4): 239–241.
75% of PCOS patients are obese
• Relative risk of MI is
7.4 times higher wrt
age matched
controls.
• risk of diabetes
associated death.
• PCO is present in 42
% of CVD patients.
J.Clin.Endocrinol.Metab., December 2013
PCOS and metabolic syndrome
The use of insulin lowering or insulin
sensitizing therapy may help to
improve ovarian function and
menstrual cyclicity.
Word “M”in the PCOS world
First being - Metformin
Miracle pill - Myoinositol
MYO-INOSITOL and METFORMIN
Myo-
inositol
Improves
insulin
sensitivity Decreases
insulin
resistance
levels
Improves
glucose
utilization
Restores
menstruation
and normal
ovulation
Reduces free
testosterone
Improves
pregnancy
rate
MYO-INOSITOL - takes
TOTAL CARE OF SYMPTOMS
Insulin acts like a key
which can open the
door on the cell surface
1
• Insulin binds to its receptor forms a complex called
insulin receptor substrate (IRS).
2
• IRS stimulates messenger called PI 3 kinase
3
• Activated PI 3 kinase activates GLU T 4
4
• Glucose is then taken by GLUT 4 through
glucose channel for utilizing energy.
5
• Then IRS complex breaks down releasing
the receptor to go back to its original site.
Phosphatidyl inositol 3-kinase is the
key messenger
• We need production & activation of PI 3 kinase
for normal cell glucose metabolism.
• Inositol produces as well as activates PI3 kinase
Inositol acts as a precursor for PI 3 kinase
Fertility and Sterility Volume 86, Issue 3, Supplement 1, September 2006, S461
J Pediatr Endocrinol Metab 2000;13 Suppl 5:1295-8
What is the connection
between PCOS and
inositols ???
DIABETES CARE 2006, 29, 300-305
Inositol levels in PCOS and Normal women
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
PCOS Subjects Normal Subjects
0.1
0.19
p=0.035
0
0.5
1
1.5
2
2.5
PCOS Subjects Normal Subjects
2.3
0.7
p= 0.043
Diabetes Care 2006;29:300–305
Plasma inositol (µmol/l) 24 h urinary inositol ((µmol/l/day)
Normal Plasma inositol (µmol/l) levels – 0.13-0.28
0
2
4
6
8
10
12
14
16
PCOS Subjects Normal
Subjects
15.3
2.7
p= 0.001
Inositol clearance levels in PCOS and
Normal women
Diabetes Care 29:300–305, 2006
UrinaryclearanceofInositol
(ml/min)
5 -6 times
more Urinary
clearance of
Inositol in PCOS
Could inositols be
considered to
treat PCOD ???
Myoinositol is not a drug
• It is naturally occuring
one of the nine isomer
of a C6 sugar alcohol
that belongs to the
vitamin B complex
group (B 7 )
• Synthesised in the liver
from glucose in our body
• Water soluble so each
dose is well tolerated
and is devoid of toxicity
It is commonly found in fruits
(grapefruit being a rich source),
vegetables (leafy vegetables the lowest)
and in all foods containing seeds
(beans, almonds and walnuts the highest).
Enzyme Epimerase converts
Myo inositol to D chiro Inositol
Conversion is insulin dependent
When insulin resistance occurs,
the conversion rate is affected
Excess insulin in the ovary
triggers Epimerasation
In overweight PCOS BMI > 25
• The insulin resistance
is very high.
• Epimerase activity is
triggered.
• Disturbs the
physiological 40 : 1
plasma ratio of Myo-
inositol : D Chiro
Inositol.
Insulin regulates blood glucose
by two ways
1) Promoting
glucose cell uptake
2) Glycogen synthesis
Eur.Rev.Med.Pharmacol.Sci., 2013
Insulin action needs
“second messengers”
MYO promotes glucose cell
intake
DCI stimulates glycogen
synthesis.
DCI is present in high
concentrations in glycogen
storage tissue (liver,
muscles and fat)
low in tissue needing
elevated energy levels
(brain, ovary, heart).
Myo – inositol
• Acts at ovary
• Increases glucose cell
intake
• Normalises LH :FSH ratio
• Increases oocytes quality
• Reduces the amount of
FSH used during IVF
cycles
• Improves IVF results
DCI
• Acts at peripheral tissues
• Stimulates glycogen
synthesis
• Reduces IR
• Increases insulin sensitivity
• Reduces hyperinsulinemia
• No effect at ovarian level
• No direct effect on fertility
• Reduces risk of metabolic
syndrome
• 19 out of 22 obese pts
ovulated (1.2 mgm/day)
• These results were not
confirmed in second
clinical trial when double
dose of DCI was given.
• Negative effect of DCI
at ovaryNestler et al 1999
The DCI “paradox” in the ovary
In overwt. PCOS
High Insulin levels
increases conversion of
MI to DCI in the ovary
Ovary unlike other tissues
never shows insulin resistance
The DCI “paradox” in the ovary
• In the ovary, MYO
is involved in FSH
signalling, while
• DCI is responsible
for insulin-mediated
testosterone
production.
Endocrine J., 2014
Net result is that in the ovary
• Increase DCI
• Promotes androgen
synthesis
• MI depletion
• Worsens the energy
state of the occyctes
These events together impair FSH
signalling and oocyte quality
Treat PCOS the right way !!
MI/DCI physiological plasma ratio
0
10
20
30
40
50
Study 1 Study 2 Study 1+2
Clinical Evidences for
MYO-INOSITOL and D –
chiro inositol combination
50 overwt. PCOS
Treatment results seen at 3 & 6 mnths
Significant improvement in plasma
glucose,insulin concentration at 3 months
Improvement in total testosterone and
SHBG was seen at both 3 and 6 months
20 overwt. PCOS
With combination therapy a significant
improvement was seen in
• Lipid profile
• BMI
• Waist : Hip ratio
• Blood pressure
• Homa index
Thus……
Combined treatment in physiological
ratio of 40 : 1 is able to restore
both hormonal and metabolic
parameters in overweight PCOS
women earlier than with MI alone
And hence the
Rationale of
40 : 1
MI : DCI
No drug interactions documented yet
• Start the treatment
as soon as the
diagnosis of PCOD is
made
• Dose is 2 grams of
MYO and 50 mg of
DCI twice a day
(powder).
• If taken as powder ,
presence of caffiene
decreases its
absorption
Caffeine-induced MYO malabsorption
Carry Home Message
PCOD treatment
is a challenge.
Treatment should address the
root cause.
Best therapy should
include a 360°
approach to the
problem, taking into
consideration the
complexity of the
syndrome.
Combined therapy may be
the first line approach in
overweight PCOS
European Review for Medical and
Pharmacological Sciences
ADDRESS
11 Gagan Vihar, Near Karkari
Morh Flyover, Delhi - 51
CONTACT US
9650588339, 011-22414049,
WEBSITE :
www.lifecarecentre.in
www.drshardajain.com
www.lifecareivf.com
E-MAIL ID
Sharda.lifecare@gmail.com
Lifecarecentre21@gmail.com
info@lifecareivf.com
&
Thank You

More Related Content

What's hot

PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
Lifecare Centre
 
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
Management of Adolescent PCODMade Easy ,Dr. Sharda Jain  Dr. Jyoti Agarwal...Management of Adolescent PCODMade Easy ,Dr. Sharda Jain  Dr. Jyoti Agarwal...
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
Lifecare Centre
 
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
Management of INFERTILITY in PCOD Difficulties & SolutionsMade Easy , Dr....Management of INFERTILITY in PCOD Difficulties & SolutionsMade Easy , Dr....
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
Lifecare Centre
 

What's hot (20)

Baiju dhea 15.11.12
Baiju dhea 15.11.12Baiju dhea 15.11.12
Baiju dhea 15.11.12
 
Dhea jdr
Dhea jdrDhea jdr
Dhea jdr
 
The Indian Story Of PCOD
The Indian Story Of PCODThe Indian Story Of PCOD
The Indian Story Of PCOD
 
Pcos
PcosPcos
Pcos
 
Recurrent pregnancy losses managing the unexplained
Recurrent pregnancy losses   managing the unexplainedRecurrent pregnancy losses   managing the unexplained
Recurrent pregnancy losses managing the unexplained
 
Pcos
PcosPcos
Pcos
 
Recent updates in ovulation induction in pcos
Recent updates in ovulation induction in  pcosRecent updates in ovulation induction in  pcos
Recent updates in ovulation induction in pcos
 
Polycystic Ovary Syndrome: Current Views
Polycystic Ovary Syndrome: Current ViewsPolycystic Ovary Syndrome: Current Views
Polycystic Ovary Syndrome: Current Views
 
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 
Polycystic ovarian syndrome (pcos)
Polycystic ovarian syndrome (pcos)Polycystic ovarian syndrome (pcos)
Polycystic ovarian syndrome (pcos)
 
Management of adolescent pcosfinal
Management of adolescent pcosfinalManagement of adolescent pcosfinal
Management of adolescent pcosfinal
 
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
Management of Adolescent PCODMade Easy ,Dr. Sharda Jain  Dr. Jyoti Agarwal...Management of Adolescent PCODMade Easy ,Dr. Sharda Jain  Dr. Jyoti Agarwal...
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
 
Polycystic ovary syndrome
Polycystic ovary syndromePolycystic ovary syndrome
Polycystic ovary syndrome
 
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
Management of INFERTILITY in PCOD Difficulties & SolutionsMade Easy , Dr....Management of INFERTILITY in PCOD Difficulties & SolutionsMade Easy , Dr....
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
 
Polycystic Ovary Syndrome (PCOS): Symptoms, Causes and Treatment
Polycystic Ovary Syndrome (PCOS): Symptoms, Causes and TreatmentPolycystic Ovary Syndrome (PCOS): Symptoms, Causes and Treatment
Polycystic Ovary Syndrome (PCOS): Symptoms, Causes and Treatment
 
PCOD,How are they different ??Difficulties & Solutions made Easy , Dr. Sharda...
PCOD,How are they different ??Difficulties & Solutions made Easy , Dr. Sharda...PCOD,How are they different ??Difficulties & Solutions made Easy , Dr. Sharda...
PCOD,How are they different ??Difficulties & Solutions made Easy , Dr. Sharda...
 
PCOS
PCOSPCOS
PCOS
 
Pcos
PcosPcos
Pcos
 
Dydrogesterone का नया अवतार (Part 1) Dr Sharda Jain
Dydrogesterone का नया अवतार (Part 1) Dr Sharda Jain Dydrogesterone का नया अवतार (Part 1) Dr Sharda Jain
Dydrogesterone का नया अवतार (Part 1) Dr Sharda Jain
 

Similar to Pcos & dci & m

PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
nutritionistrepublic
 
PHYSIOLOGY OF POLYCYSTIC OVARY SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLYCYSTIC OVARY   SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...PHYSIOLOGY OF POLYCYSTIC OVARY   SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLYCYSTIC OVARY SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
nutritionistrepublic
 
Pcos & Infertility by dr alka mukherjee nagpur m.s. India
Pcos & Infertility by dr alka mukherjee nagpur m.s. IndiaPcos & Infertility by dr alka mukherjee nagpur m.s. India
Pcos & Infertility by dr alka mukherjee nagpur m.s. India
alka mukherjee
 

Similar to Pcos & dci & m (20)

Myo-inisotol in ART PCO wemen
Myo-inisotol in ART PCO wemenMyo-inisotol in ART PCO wemen
Myo-inisotol in ART PCO wemen
 
ADCVANCE NOVEL MANAGEMENT TREATMENT OF PCOS
ADCVANCE NOVEL  MANAGEMENT TREATMENT OF PCOSADCVANCE NOVEL  MANAGEMENT TREATMENT OF PCOS
ADCVANCE NOVEL MANAGEMENT TREATMENT OF PCOS
 
PCOS- Is obesity a concern
PCOS- Is obesity a concernPCOS- Is obesity a concern
PCOS- Is obesity a concern
 
Use of Melatonin in ART with Focus on Combined effect of melatonin with Clo...
Use of Melatonin in ART with Focus on  Combined effect of melatonin with  Clo...Use of Melatonin in ART with Focus on  Combined effect of melatonin with  Clo...
Use of Melatonin in ART with Focus on Combined effect of melatonin with Clo...
 
PCOS BY DR FATIMA .pptx
PCOS BY DR FATIMA .pptxPCOS BY DR FATIMA .pptx
PCOS BY DR FATIMA .pptx
 
Pcos
PcosPcos
Pcos
 
PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLY CYSTIC OVARY-CLINICAL MANIFESTATIONS AND NUTRITIONAL INTER...
 
Insulin sensitisers
Insulin sensitisersInsulin sensitisers
Insulin sensitisers
 
POLYCYSTIC OVARIAN SYNDROME
POLYCYSTIC OVARIAN SYNDROME POLYCYSTIC OVARIAN SYNDROME
POLYCYSTIC OVARIAN SYNDROME
 
K0556366
K0556366K0556366
K0556366
 
Polycystic ovarian syndrome and role of physical therapy (1)
Polycystic ovarian syndrome and role of physical therapy (1)Polycystic ovarian syndrome and role of physical therapy (1)
Polycystic ovarian syndrome and role of physical therapy (1)
 
PCO ROAD MAP.pdf
PCO ROAD MAP.pdfPCO ROAD MAP.pdf
PCO ROAD MAP.pdf
 
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
 
PHYSIOLOGY OF POLYCYSTIC OVARY SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLYCYSTIC OVARY   SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...PHYSIOLOGY OF POLYCYSTIC OVARY   SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
PHYSIOLOGY OF POLYCYSTIC OVARY SYNDROME: ITS CLINICAL AND NUTRITIONAL INTER...
 
PCOS presentation 11.ppt
PCOS  presentation 11.pptPCOS  presentation 11.ppt
PCOS presentation 11.ppt
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
 
A STUDY ON QOL & EFFECTOF COQ10 IN PCOS
A STUDY ON QOL & EFFECTOF COQ10 IN PCOSA STUDY ON QOL & EFFECTOF COQ10 IN PCOS
A STUDY ON QOL & EFFECTOF COQ10 IN PCOS
 
Infertility and PCOS
Infertility and PCOSInfertility and PCOS
Infertility and PCOS
 
PPT- FUROCYST- Lion club.pptx
PPT- FUROCYST- Lion club.pptxPPT- FUROCYST- Lion club.pptx
PPT- FUROCYST- Lion club.pptx
 
Pcos & Infertility by dr alka mukherjee nagpur m.s. India
Pcos & Infertility by dr alka mukherjee nagpur m.s. IndiaPcos & Infertility by dr alka mukherjee nagpur m.s. India
Pcos & Infertility by dr alka mukherjee nagpur m.s. India
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
Avinash Rai
 

Recently uploaded (20)

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How to the fix Attribute Error in odoo 17
How to the fix Attribute Error in odoo 17How to the fix Attribute Error in odoo 17
How to the fix Attribute Error in odoo 17
 
The impact of social media on mental health and well-being has been a topic o...
The impact of social media on mental health and well-being has been a topic o...The impact of social media on mental health and well-being has been a topic o...
The impact of social media on mental health and well-being has been a topic o...
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
The Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. HenryThe Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. Henry
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
B.ed spl. HI pdusu exam paper-2023-24.pdf
B.ed spl. HI pdusu exam paper-2023-24.pdfB.ed spl. HI pdusu exam paper-2023-24.pdf
B.ed spl. HI pdusu exam paper-2023-24.pdf
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringBasic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
 
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
Keeping Your Information Safe with Centralized Security Services
Keeping Your Information Safe with Centralized Security ServicesKeeping Your Information Safe with Centralized Security Services
Keeping Your Information Safe with Centralized Security Services
 
NCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdfNCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 

Pcos & dci & m

  • 1. What is 40 : 1 In management of Dr. Jyoti Agarwal Dr. Sharda Jain Dr. Jyoti Bhaskar
  • 2. Not end of the story Today knowledge regarding PCOS has revived and efforts have been undertaken to explore new options created significant development in t/t of PCOD
  • 3.
  • 4. Indian Journal of Endocrinology and Metabolism, 2011 Central player : IR
  • 5. Insulin Resistance A pathophysiological contributor in 50 – 80 % of the PCOS women Indian J Endocrinol Metab. 2011 Oct-Dec; 15(4): 239–241.
  • 6. 75% of PCOS patients are obese
  • 7. • Relative risk of MI is 7.4 times higher wrt age matched controls. • risk of diabetes associated death. • PCO is present in 42 % of CVD patients. J.Clin.Endocrinol.Metab., December 2013 PCOS and metabolic syndrome
  • 8. The use of insulin lowering or insulin sensitizing therapy may help to improve ovarian function and menstrual cyclicity.
  • 9. Word “M”in the PCOS world First being - Metformin Miracle pill - Myoinositol
  • 12. Insulin acts like a key which can open the door on the cell surface
  • 13. 1 • Insulin binds to its receptor forms a complex called insulin receptor substrate (IRS). 2 • IRS stimulates messenger called PI 3 kinase 3 • Activated PI 3 kinase activates GLU T 4 4 • Glucose is then taken by GLUT 4 through glucose channel for utilizing energy. 5 • Then IRS complex breaks down releasing the receptor to go back to its original site.
  • 14. Phosphatidyl inositol 3-kinase is the key messenger • We need production & activation of PI 3 kinase for normal cell glucose metabolism. • Inositol produces as well as activates PI3 kinase Inositol acts as a precursor for PI 3 kinase Fertility and Sterility Volume 86, Issue 3, Supplement 1, September 2006, S461 J Pediatr Endocrinol Metab 2000;13 Suppl 5:1295-8
  • 15. What is the connection between PCOS and inositols ???
  • 16. DIABETES CARE 2006, 29, 300-305
  • 17. Inositol levels in PCOS and Normal women 0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18 0.2 PCOS Subjects Normal Subjects 0.1 0.19 p=0.035 0 0.5 1 1.5 2 2.5 PCOS Subjects Normal Subjects 2.3 0.7 p= 0.043 Diabetes Care 2006;29:300–305 Plasma inositol (µmol/l) 24 h urinary inositol ((µmol/l/day) Normal Plasma inositol (µmol/l) levels – 0.13-0.28
  • 18. 0 2 4 6 8 10 12 14 16 PCOS Subjects Normal Subjects 15.3 2.7 p= 0.001 Inositol clearance levels in PCOS and Normal women Diabetes Care 29:300–305, 2006 UrinaryclearanceofInositol (ml/min) 5 -6 times more Urinary clearance of Inositol in PCOS
  • 19. Could inositols be considered to treat PCOD ???
  • 20. Myoinositol is not a drug • It is naturally occuring one of the nine isomer of a C6 sugar alcohol that belongs to the vitamin B complex group (B 7 ) • Synthesised in the liver from glucose in our body • Water soluble so each dose is well tolerated and is devoid of toxicity
  • 21. It is commonly found in fruits (grapefruit being a rich source), vegetables (leafy vegetables the lowest) and in all foods containing seeds (beans, almonds and walnuts the highest).
  • 22. Enzyme Epimerase converts Myo inositol to D chiro Inositol Conversion is insulin dependent
  • 23. When insulin resistance occurs, the conversion rate is affected Excess insulin in the ovary triggers Epimerasation
  • 24. In overweight PCOS BMI > 25 • The insulin resistance is very high. • Epimerase activity is triggered. • Disturbs the physiological 40 : 1 plasma ratio of Myo- inositol : D Chiro Inositol.
  • 25. Insulin regulates blood glucose by two ways 1) Promoting glucose cell uptake 2) Glycogen synthesis Eur.Rev.Med.Pharmacol.Sci., 2013
  • 26. Insulin action needs “second messengers” MYO promotes glucose cell intake DCI stimulates glycogen synthesis. DCI is present in high concentrations in glycogen storage tissue (liver, muscles and fat) low in tissue needing elevated energy levels (brain, ovary, heart).
  • 27. Myo – inositol • Acts at ovary • Increases glucose cell intake • Normalises LH :FSH ratio • Increases oocytes quality • Reduces the amount of FSH used during IVF cycles • Improves IVF results DCI • Acts at peripheral tissues • Stimulates glycogen synthesis • Reduces IR • Increases insulin sensitivity • Reduces hyperinsulinemia • No effect at ovarian level • No direct effect on fertility • Reduces risk of metabolic syndrome
  • 28. • 19 out of 22 obese pts ovulated (1.2 mgm/day) • These results were not confirmed in second clinical trial when double dose of DCI was given. • Negative effect of DCI at ovaryNestler et al 1999
  • 29. The DCI “paradox” in the ovary In overwt. PCOS High Insulin levels increases conversion of MI to DCI in the ovary Ovary unlike other tissues never shows insulin resistance
  • 30. The DCI “paradox” in the ovary • In the ovary, MYO is involved in FSH signalling, while • DCI is responsible for insulin-mediated testosterone production. Endocrine J., 2014
  • 31. Net result is that in the ovary • Increase DCI • Promotes androgen synthesis • MI depletion • Worsens the energy state of the occyctes These events together impair FSH signalling and oocyte quality
  • 32. Treat PCOS the right way !!
  • 33. MI/DCI physiological plasma ratio 0 10 20 30 40 50 Study 1 Study 2 Study 1+2
  • 34. Clinical Evidences for MYO-INOSITOL and D – chiro inositol combination
  • 35. 50 overwt. PCOS Treatment results seen at 3 & 6 mnths
  • 36. Significant improvement in plasma glucose,insulin concentration at 3 months Improvement in total testosterone and SHBG was seen at both 3 and 6 months
  • 38. With combination therapy a significant improvement was seen in • Lipid profile • BMI • Waist : Hip ratio • Blood pressure • Homa index
  • 39. Thus…… Combined treatment in physiological ratio of 40 : 1 is able to restore both hormonal and metabolic parameters in overweight PCOS women earlier than with MI alone
  • 40. And hence the Rationale of 40 : 1 MI : DCI
  • 41.
  • 42.
  • 43. No drug interactions documented yet • Start the treatment as soon as the diagnosis of PCOD is made • Dose is 2 grams of MYO and 50 mg of DCI twice a day (powder). • If taken as powder , presence of caffiene decreases its absorption Caffeine-induced MYO malabsorption
  • 44. Carry Home Message PCOD treatment is a challenge. Treatment should address the root cause. Best therapy should include a 360° approach to the problem, taking into consideration the complexity of the syndrome.
  • 45. Combined therapy may be the first line approach in overweight PCOS European Review for Medical and Pharmacological Sciences
  • 46. ADDRESS 11 Gagan Vihar, Near Karkari Morh Flyover, Delhi - 51 CONTACT US 9650588339, 011-22414049, WEBSITE : www.lifecarecentre.in www.drshardajain.com www.lifecareivf.com E-MAIL ID Sharda.lifecare@gmail.com Lifecarecentre21@gmail.com info@lifecareivf.com & Thank You